ABOUT US
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.
VIDEOS
FEATURED PRODUCTS
-
![MabSelect VL Affinity Resin]( "Protein L Resin For Affinity Capture")
MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.
-
![Cytiva HyClone]( "Hyclone Cell Boost Supplements")
Supplements cell culture with amino acids, vitamins, and glucose and manufactured to meet cGMP manufacturing standards and QC specifications.
-
![cytiva_logo_hz_color_pos_rgb (002)]( "Chromatography Systems")
ÄKTA™ chromatography systems can handle both simple and complex purification tasks and accelerate daily routines. All systems are controlled by UNICORN™ software, a common control platform and user interface for all scales of operation.
-
![cytiva_logo_hz_color_pos_rgb (002)]( "Bioprocessing Filtration")
Cytiva provides filtration solutions and support for integrated bioprocessing applications at every step and every scale of the drug development, validation and manufacturing process.
-
![cytiva_logo_hz_color_pos_rgb (002)]( "Label-Free Interaction Analytics")
We offer a range of systems, accessories, and reagents for label-free analysis using microcalorimetry or surface plasmon resonance (SPR). These techniques provide information-rich, real time data without the use of labels.
-
![ÄKTA pure]( "Fast Purification - ÄKTA pure Chromatography System")
ÄKTA pure™ is a flexible and intuitive chromatography system for fast purification of proteins, peptides, and nucleic acids from microgram levels to tens of grams of target product in research scale applications. ÄKTA pure™ is a reliable system where hardware and UNICORN™ system control software are designed to work together with columns and media to meet any purification challenge.
-
![ÄKTA start]( "Easy-To-Use Preparative System, For Laboratory-Scale Protein Purification")
ÄKTA start™ is a preparative chromatography system for laboratory-scale protein purification. ÄKTA start™ is designed as a stand-alone system, with an intuitive design, simple flow path, and user-friendly interface. With ÄKTA start™, it is easy to purify a wide variety of proteins using built-in quick start methods or predefined templates, or by creating your own methods.
-
![biacore protein interaction system]( "Biacore Systems: Protein Interaction And Stability Analysis")
Biacore protein interaction and stability analysis systems characterized molecules in terms of their specificity and selectivity of interaction, on and off rates (kinetics), and binding strength (affinity).
BROCHURES AND DATASHEETS
WEBINARS
APPLICATION NOTES
- Alkaline Stability Of Modern Protein A Chromatography Resins
- AAV Full/Empty Capsid Separation Using Mechanistic Modeling
- Recombinant Protein Purification Optimization With HIC
- Explore Protein Interactions Beyond Affinity To Boost Your Academic Research
- Capture Of Histidine-Tagged Molecules Using Biacore His Capture Kit
- Chromatography Method For Purifying Infectious Virus Particles
- Purifying Tagged Proteins Using A Small And Compact LC System
- Epitope Binning: A Critical Step In Antibody Selection
- EDGE Confocal Imaging Technology
- Converting From ELISA To Biacore SPR Assays
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
-
![antibody molecules-GettyImages-2165626333]( "ADC Development Grows More Complex — SPR Insights Bring Clarity")
Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
![mammlian-cell-lines-GettyImages-1690936576]( "FDA's New Flexible CMC Framework For CGT")
The FDA is rethinking CMC oversight for cell and gene therapies, prioritizing science‑based justification over rigid validation models. Learn how this lifecycle‑focused approach could reduce burden.
-
![GettyImages-2183428971-lab-cleanroom]( "Industry Innovators: APAC's Sharp Advanced Therapeutics Edge")
APAC is rapidly advancing its role in the global therapeutics landscape, fueled by faster development models. Learn how this momentum is reshaping expectations for innovation and commercialization.
-
![GettyImages-2213157127-drug-formulation-discovery-pipette-liquid-vial]( "How One Biotech Company Is Accelerating The Drug Discovery Workflow")
See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
-
![mRNA GettyImages-1428646288]( "Advanced Therapies Going Mainstream: Are We There Yet?")
Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.
-
![GettyImages-2036497889-lab-computer-research]( "Collaboration An Untapped Fuel For Driving Biopharma R&D")
Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.
-
![GettyImages-1413607446-vial-syringe-liquid-scientist-glove]( "Your Biosimilar, Your Journey")
With many blockbuster drug patents set to expire by 2030, the market is ripe for biosimilar developers to stake their claim. To succeed, they must be strategic and compliant.
-
![Pharmaceutical-regulations-GettyImages-1423114910]( "Navigating The Regulatory Space To Biosimilar Approval")
The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.
-
![Organs-body-organoid-study-GettyImages-1157550305]( "Ready To Demystify Organoids?")
Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.
-
![GettyImages-1284610189-laboratory-research-development-cell-culture]( "Face The Unknown: Key Bispecific Antibody Discoveries")
Bispecific antibodies (BsAbs) are revolutionizing biopharmaceuticals with enhanced therapeutic potential. Learn how advanced design tools and expert support streamline BsAb development from concept to clinic.
